Women with phenotypes A and B usually also have menstrual dysfunction, increased risk for metabolic syndrome (increased insulin secretion and insulin resistance), dyslipidemia, hepatic steatosis, and a higher incidence of obesity. This evidence concerns the gene INS and fatty liver disease.